fda changes to semaglutide approves Ozempic® (semaglutide) as the only GLP-1 RA reduce the risk of worsening kidney disease and cardiovascular death in adults with type 2 diabetes and chronic kidney disease 🚨 FDA Moves to Permanently

Hum Nutr Metabol

Yan, C., & Zhang, W

CrossRef Basic and Translational Research Phosphodiesterase 5 Inhibitor Improves Insulin Sensitivity by Regulating Adipose Tissue Macrophage Polarization in Diet-Induced Obese Mice Dan-Gyeong Song, Seongwon Pak, Dae-Chul Shin, Shindy Soedono, Kae Won Cho, Yejin Park, Subin Moon, Sooyeon Jang, Saeha Kim, Sang-Won Han, Keunwook Lee, Jong-Hee Sohn, Chan Hee Lee Diabetes Metab J

10.1016/j.brainresbull.2023.110763 7 ChenB

Even phentermine and semaglutide combinations raise more flags

Alternative, additional, and/or improved compositions and methods for the treatment of autism spectrum disorders, and particular traits or symptoms thereof, are desirable